JDRF 100 Challenge for World Diabetes Day
Bethany Cooney
My Story
I'm taking on the 100 Challenge for JDRF, the charity that funds research to treat, prevent and cure type 1 diabetes.
This condition affects 400,000 people in the UK, with over 29,000 of them children. JDRF aims to create a world without type 1 diabetes. Until that day, your support is vital to help fund world-class research, improving treatments until JDRF finds the cure.
2021 has been a phenomenal year for JDRF in regards to research progress. The immunotherapy drug Teplizamab which can delay type 1 for up to 3 years is being reviewed by the FDA thanks to JDRF research. Alongside the Artificial Pancreas App technology being trialled for the NHS. However, funding has declined due to the impact of Covid. Now, more than ever, we need your support to keep this momentum going so that we can find even better treatments and eventually a cure.
Please support me and JDRF by sponsoring my JDRF 100 Challenge.
Thank you!
My Story
I'm taking on the 100 Challenge for JDRF, the charity that funds research to treat, prevent and cure type 1 diabetes.
This condition affects 400,000 people in the UK, with over 29,000 of them children. JDRF aims to create a world without type 1 diabetes. Until that day, your support is vital to help fund world-class research, improving treatments until JDRF finds the cure.
2021 has been a phenomenal year for JDRF in regards to research progress. The immunotherapy drug Teplizamab which can delay type 1 for up to 3 years is being reviewed by the FDA thanks to JDRF research. Alongside the Artificial Pancreas App technology being trialled for the NHS. However, funding has declined due to the impact of Covid. Now, more than ever, we need your support to keep this momentum going so that we can find even better treatments and eventually a cure.
Please support me and JDRF by sponsoring my JDRF 100 Challenge.
Thank you!
Bethany Cooney is fundraising towards
